Derek Chan
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 3
- Cancer Cells and Metastasis 1
- Bone health and treatments 1
- Peptidase Inhibition and Analysis 1
- Immunology top 2%
- Cancer Research top 2%
- Biotechnology top 5%
- Molecular Biology top 10%
- Fibroblast Growth Factor Research 1
-
- Retinal Imaging and Analysis 1
-
- Primary Care and Health Outcomes 1
-
- Chronic Disease Management Strategies 1
- Co-authors
- David A. TuvesonChristine FeigAlbrecht NeeßeNatalie CookAarthi GopinathanDuncan I. JodrellAndrew DeonarineJames O. Jones
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Derek Chan
10 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 2.8k
- Immunology 1.2k
- Cancer Research 722
- Biotechnology 188
- Molecular Biology 1.0k
Countries citing papers authored by Derek Chan
This map shows the geographic impact of Derek Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Chan more than expected).
Fields of papers citing papers by Derek Chan
This network shows the impact of papers produced by Derek Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Chan. The network helps show where Derek Chan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Derek Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2022 | 4 | |
| 3 | 2020 | 2 | |
| 4 | What are the most common conditions in primary care? Systematic review.breakdown → | 2018 | 293 |
| 5 | 2014 | 53 | |
| 6 | 2013 | 118 | |
| 7 | Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancerbreakdown → | 2013 | 1490 |
| 8 | Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancerbreakdown → | 2012 | 837 |
| 9 | The Pancreas Cancer Microenvironmentbreakdown → | 2012 | 1019 |
| 10 | 2001 | 11 |
About Derek Chan
Derek Chan is a scholar working on Geriatrics and Gerontology, Molecular Medicine, Oncology, Health and General Health Professions, having authored 10 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (3 papers), Retinal Imaging and Analysis (1 paper), Cancer Cells and Metastasis (1 paper), Bone health and treatments (1 paper), Primary Care and Health Outcomes (1 paper), Fibroblast Growth Factor Research (1 paper), Chronic Disease Management Strategies (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (2.8k citations), Immunology (1.2k citations), Cancer Research (722 citations), Biotechnology (188 citations) and Molecular Biology (1.0k citations). Derek Chan has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include David A. Tuveson, Christine Feig, Albrecht Neeße, Natalie Cook, Aarthi Gopinathan, Duncan I. Jodrell, Andrew Deonarine, James O. Jones, Edward W. Roberts and Douglas T. Fearon. Their work appears in journals such as Gut, Clinical Cancer Research, Epilepsy Research, Disease Management & Health Outcomes and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.